UBS Group
MJN

UBS Group’s Mead Johnson Nutrition Company MJN Stock Holding History

UBS Group’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,824
Closed -$934K – 8593
2015
Q4 		$934K Sell
11,824
-30,600
-72% -$2.41M ﹤0.01% 3458
2015
Q3 		$2.99M Buy
42,424
+32,181
+314% +$2.65M ﹤0.01% 2386
2015
Q2 		$924K Hold
10,243
– – ﹤0.01% 3635
2015
Q1 		$1.03M Buy
+10,243
New +$1.03M ﹤0.01% 3548

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

UBS Group's MJN Position: Q2 2017 in Review

UBS Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,947,990 shares — an estimated $174M sold.

UBS Group first reported a position in MJN in Q4 2014 and held it in 10 quarters. The position peaked at $174M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • UBS Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • UBS Group sold 1,947,990 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $174M.
  • UBS Group first reported a position in Mead Johnson Nutrition Company in Q4 2014 and held it in 10 quarters.
  • UBS Group's Mead Johnson Nutrition Company position peaked at $174M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.